扩髓带锁髓内针治疗胫腓骨骨折

Reamed interlocking intramedullary nail in the treatment of tibial and fibular fractures

回顾分析经扩髓带锁髓内针治疗的 38例胫腓骨骨折的疗效 ;最终结果采用Jouner Wruh评分标准评定 ,平均随访 14 6 (6～ 32 )个月。结果 :经扩髓带锁内针治疗胫腓骨骨折 ,优 33例 ,良 4例 ,中 1例。无锁定螺钉和髓内针折断 ,无腓总神经损伤 ,无深部感染和畸形愈合。扩髓带锁髓内针在治疗胫腓骨骨折中既能起到稳定可靠的固定作用 ,又能减少骨折局部软组织及血运的破坏 。

To analyse retrospectively the results of thirty eight fractures of the tibial and fibular treated with reamedintramedullary interlocking nail from May 1997 to June 2000. The patients were followed for an average of 14 6(range:6～32)months. The mean age was 32 8(range:18～64)years, the sex distribution was 29 males and 9 females. 26 fractures were closed (One case was failure of plate and screws) and 12 were opened: 6 were graded Ⅰ,4 were Ⅱ,2 Ⅲa, according to Gustilo's classification. A solid union was achieved in all patients within a period of 6 months. there were no deep infections except one case of superficial infection. Cases of deformity or peroneal nerve injury were no noticed. It is believed that reamed intramedullary interlocking nail allows a stable and safety fixation in open or closed tibial and fibular fractures.